Lederer & Keller – Germany 2018
This Munich patent attorney firm is best known for its solid expertise in pharmaceuticals, biotech and chemicals patents. Besides prosecution work for regular clients like Teva or Sandoz, L&K is often seen in litigation, e.g. for Ratiopharm against Orion Pharma involving the sedative dexmedetomidine or for Hexal in the dispute with Bayer over Xarelto. Such clients secure the patent attorneys’ excellent reputation for pharmaceuticals proceedings on the side of generics manufacturers.
Pharmaceuticals, biotech and chemicals patents; litigation.
Dr. Günter Keller (“very strong biotech expertise, vast litigation experience”, competitor), Dr. Dipl.-Chem. Michael Best (“outstanding technical expertise and experienced litigation tactician”, competitor).
4 patent attorneys
Prosecution and litigation for generics manufacturers.
Litigation: Ratiopharm against Orion Pharma regarding dexmedetomidine; Hexal against Bayer concerning dosage patent for rivaroxaban (both public knowledge). Prosecution: filing and opposition suits for Teva/Ratiopharm, Sandoz, Solvay, Hain Lifescience, Microgen and Freiburg, Würzburg and Leipzig universities.